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Abstract
Background
Formation of 43S and 48S preinitiation complexes plays an important role in muscle protein
synthesis. There is no muscle-wasting mouse model caused by a repressed 43S preinitia-
tion complex assembly.
Objective
The aim of the present study was to develop a convenient mouse model of skeletal muscle
wasting with repressed 43S preinitiation complex assembly.
Material and methods
A ligand-activatable PERK derivative Fv2E-PERK causes the phosphorylation of eukaryotic
initiation factor 2α (eIF2α), which inhibits 43S preinitiation complex assembly. Thus, muscle
atrophic phenotypes, intracellular signaling pathways, and intracellular free amino acid pro-
files were investigated in human skeletal muscle α-actin (HSA) promoter-driven Fv2E-
PERK transgenic (Tg) mice.
Results
HSA-Fv2E-PERK Tg mice treated with the artificial dimerizer AP20187 phosphorylates
eIF2α in skeletal muscles and leads to severe muscle atrophy within a few days of ligand
injection. Muscle atrophy was accompanied by a counter regulatory activation of mTORC1
signaling. Moreover, intracellular free amino acid levels were distinctively altered in the skel-
etal muscles of HSA-Fv2E-PERK Tg mice.
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Conclusions
As a novel model of muscle wasting, HSA-Fv2E-PERK Tg mice provide a convenient tool
for studying the pathogenesis of muscle loss and for assessing putative therapeutics.
Introduction
Skeletal muscles are involved in fundamental functions, such as enabling locomotion, main-
taining body temperature, and storing nutrients. Muscle mass is determined by a balance
between anabolic and catabolic processes. Skeletal muscle wasting occurs in several disorders,
including sarcopenia, infection, cancer cachexia, disuse and denervated muscle [1, 2]. Muscle
wasting results from an imbalance between protein degradation and protein synthesis [3].
Protein degradation is controlled by three proteolytic pathways, i.e., the ubiquitin–protea-
some, autophagy–lysosome, and calcium-dependent calpain systems. Calpain is suggested to
be the early rate-limiting factor in myofibrillar proteolysis during muscle wasting [1]. They
can degrade proteins required for the assembly and scaffolding of myofibrillar proteins, such
as desmin, filamen, C-protein, tropomyosin, troponin T, troponin I, titin, nebulin, vimentin,
gelsolin, and vinculin [4]. In addition, ubiquitin–proteasome systems degrade the bulk of myo-
fibrillar proteins during muscle wasting [5, 6]. Recent studies using the genetic manipulation
of autophagy regulators revealed that a fine equilibrium of autophagic flux is necessary to pre-
serve muscle mass [7]. Excessive autophagy causes an acute muscle loss owing to the impru-
dent clearance of necessary cellular components. Insufficient autophagy causes a chronic
muscle loss due to the accumulation of damaged or aged cellular components. Thus, there is
increasing evidence that increased protein degradation due to the dysregulation of these pro-
teolytic pathways contributes to muscle wasting.
Although protein degradation is an important contributor to the development and progres-
sion of muscle wasting, an impairment of protein synthesis is also known to be involved in
muscle wasting under atrophic conditions, such as sepsis, sarcopenia, and cancer cachexia [3].
The process of protein synthesis can be divided into initiation, elongation, termination, and
recycling [8]. The initiation step plays a major role in modulating the protein synthesis rate
[9]. One of the rate-limiting steps in initiation is the recruitment of mRNA to the 43S preinitia-
tion complex by the eIF4E–eIF4G–eIF4A cap-binding complex, resulting in a complex called
the 48S preinitiation complex. Signaling through the mammalian target of rapamycin complex
1 (mTORC1) plays a key role in this process. mTORC1 phosphorylates 4EBP1 allowing cap-
dependent protein synthesis, given that unphosphorylated 4EBP1 binds to the mRNA cap and
prevents the cap-dependent mRNA binding to the 43S preinitiation complex. In addition to
4EBP1, mTORC1 also phosphorylates S6K, which is subsequently phosphorylates eIF4B, an
eIF4A helicase activator that is activated by phosphorylation, and PDCD4, an eIF4A inhibitor
that is inhibited by phosphorylation. Similar to the function of phosphorylated 4EBP1 to
enhance cap-dependent protein synthesis, PDCD and eIF4B phosphorylation causes the
release of eIF4A to interact with eIF4G and the assembly of eIF4A into the eIF4E–eIF4G–
eIF4A cap-binding complex.
Another rate-limiting step of initiation is the formation of a ternary complex comprising
eIF2, GTP, and initiator methionyl-tRNA (Met-tRNAi), which subsequently binds to the 40S
ribosomal subunit to form the 43S preinitiation complex [8]. The phosphorylation of the eIF2
α-subunit on Ser51 is a critical regulator in this process. Phosphorylated eIF2α binds and
inhibits the guanine nucleotide exchange factor eIF2B, which is required for recycling the
A novel mouse model of muscle wasting
PLOS ONE | https://doi.org/10.1371/journal.pone.0179955 June 23, 2017 2 / 16
Takeda Science Foundation, Sankyo Foundation,
Ono Medical Research Foundation, Mochida
Memorial Foundation, the Ube Foundation, Kowa
Life Science Foundation, Suzuken Memorial
Foundation, Kanae Foundation and Japan Diabetes
Foundation. The funders provided support in the
form of research grant for SO or MM, but did not
have any additional role in the study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
Competing interests: KT is employed by EA
Pharma Co., Ltd. This commercial affiliation does
not alter our adherence to PLOS ONE policies on
sharing data and materials.
GDP-bound eIF2 into the translationally active GTP-bound form. As the GTP-bound eIF2 is
hydrolyzed at a late initiation step, eIF2B activity inhibition results in the accumulation of the
GDP-bound eIF2 that has limited affinity for Met-tRNAi, leading to a decrease in protein syn-
thesis. The eIF2α phosphorylation is regulated by four eIF2α kinases, such as general control
nonderepressible 2 (GCN2), double-stranded RNA-dependent protein kinase (PKR), PKR-
like endoplasmic reticulum-associated protein kinase (PERK) and heme-regulated inhibitor
(HRI), and eIF2α phosphatases, containing CReP and GADD34 [10], all of which are activated
by distinct cellular stresses, such as amino acid deficiency for GCN2, RNA virus infection for
PKR, endoplasmic reticulum stress for PERK, and heme depletion for HRI. The eIF2α dephos-
phorylation is regulated by constitutively expressed CReP and stress-induced GADD34.
In the previous study, we explored the role of eIF2α phosphorylation in skeletal muscles
and showed that eIF2α was phosphorylated by exercise and cold exposure in skeletal muscles
and that mild eIF2α phosphorylation caused transcriptional induction to regulate energy con-
sumption [11]. Moreover, we also found that strong eIF2α phosphorylation suppressed muscle
protein synthesis [11]. Here, we further investigated the previously established transgenic mice
harboring a ligand-activated skeletal muscle-specific eIF2α phosphorylation. In the present
study, we showed that strong and constitutive eIF2α phosphorylation in skeletal muscles
induces rapid muscle wasting, offering a convenient mouse model of rapid-onset muscle wast-
ing with reduced muscle protein synthesis. This model may facilitate the development of novel
therapies for muscle wasting.
Materials and methods
Mice
HSA-Fv2E-PERK Tg mice (Accession No. CDB0514T: http://www2.clst.riken.jp/arg/TG%
20mutant%20mice%20list.html) were generated on a C57Bl/6N background and maintained
as described previously [11]. Briefly, a 4.9-kb fragment containing the human skeletal muscle
α-actin promoter (2.2 kb), the Fv2E regulatory domain (0.7 kb), the mouse PERK kinase
domain (1.7 kb), and the bovine growth hormone poly(A) sequence (0.3 kb) was constructed
and expressed in mouse skeletal muscles. Mice were genotyped using polymerase chain reac-
tion (PCR) with primers for the Fv2E domain (Table 1). AP21087 (AP; Apexbio) or vehicle
(4% ethanol, 10% polyethylene glycol-400, and 1.75% Tween-20 in water) were injected intra-
peritoneally once a day for 7 days. Mice were sacrificed using CO2 euthanasia chamber and
muscles were sampled at 8 h after last injection. All animal procedures were reviewed and
approved by the Animal Research Committee of Tokushima University and Institutional Ani-
mal Care and Use Committee of RIKEN Kobe Branch.
Table 1. PCR and RT-qPCR primer sequences.
Gene name Sense sequence (50-30) Antisense sequence (50-30) Accession no. Purpose
Fv2E AGTCATTAGGGGATGGGAGG CCGTCTCCTGGGGAGATAGT N/A Genotyping
Ddit3 GCGACAGAGCCAGAATAACA GATGCACTTCCTTCTGGAACA NM_007837.4 qPCR
Ppp1r15 ACGATCGCTTTTGGCAAC GACATGCTGGGGTCTTGG NM_008654.2 qPCR
Trib3 CGCTTTGTCTTCAGCAACTGT TCATCTGATCCAGTCATCACG NM_175093.2 qPCR
Ppargc1a CCGTAAATCTGCGGGATGATG CAGTTTCGTTCGACCTGCGTAA NM_008904.2 qPCR
Fbxo32 ACGACGTCGCAGCCAAGAAGAGAA TCCATGGCGCTCCTTCGTACTTCC NM_026346.3 qPCR
Trim63 CCTTCCTCTCAAGTGCCAAGCAGC TGGCCCTCAAGGCCTCTGCTATGTG NM_001039048.2 qPCR
Gadd45 CACTGTGTGCTGGTGACG TTCCATTCGGATGCCATCAC NM_007836.1 qPCR
Rplp0 TTTGGGCATCACCACGAAAA GGACACCCTCCAGAAAGCGA NM_007475.5 qPCR
https://doi.org/10.1371/journal.pone.0179955.t001
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RT-qPCR analysis
Total RNA was extracted from skeletal muscle samples using AGPC methods, and was used as
templates for cDNA synthesis with ReverTra Ace qPCR RT Master Mix and gDNA Remover
(Toyobo). RT-qPCR reactions were performed using Prism 7900HT or Step One Plus Real-
Time PCR Systems (Thermo Fisher) with AmpliTaq Gold1 360 Master Mix (Thermo Fisher),
EvaGreen (Biotium), and the primers listed in Table 1. Ribosomal phosphoprotein P0 (Rplp0/
36B4) mRNA was used as an internal control.
Immunoblot analysis
Muscle lysates were prepared in RIPA buffer (50-mM Tris-HCl, 150-mM NaCl, 1% NP-40,
0.1% SDS, and 0.5% sodium deoxycholate) containing protease inhibitor cocktail (Nacalai Tes-
que) and phosphatase inhibitor cocktail (Biotool) using a Polytron homogenizer (Kinematica).
The protein concentrations of lysates were measured using the bicinchoninic acid method,
and immunoblot analyses were performed as described previously [12]. Proteins were detected
using anti-PERK, anti-phospho-PERK (Thr980), anti-eIF2α, anti-phospho-eIF2α (Ser51),
anti-Akt, anti-phospho-Akt (Ser473), anti-p70 S6 kinase (S6K), anti-phospho-S6K (Thr389),
anti-eukaryotic translation initiation factor 4E (eIF4E)-binding protein (4EBP) 1, and anti-
phospho-4EBP1 (Thr37/46), which were purchased from Cell Signaling Technology. GAPDH,
which was purchased from MBL international, was used as a loading control. Bands were
detected using WesternSure ECL Substrate (Li-Cor Biosciences), and images were acquired
using an EZ-Capture II Cooled CCD Camera System (ATTO Corp.). The band intensity was
determined using ImageJ software.
Histological analyses
Skeletal muscle tissues were excised from euthanized mice, and were snap-frozen in a dry ice–
acetone bath. Cryostat sections were stained with hematoxylin and eosin (HE). The relative
cross-sectional area (CSA) was determined using ImageJ software from at least 200 muscle
fibers of individual mice.
Metabolomics analyses
Targeted profiling of amino acid metabolites was analyzed by CE–TOF/MS using an Agilent
7100 CE Capillary Electrophoresis system equipped with an Agilent 6230 Time-of-Flight mass
spectrometer (Agilent Technologies) according to the methods described previously [13]. In
brief, frozen skeletal muscle samples were homogenized with methanol containing internal
standards (H3304-1002, Human Metabolome Technology Inc.); subsequently, both chloro-
form and Milli-Q water were added in the sample solution. The solution was centrifuged, and
the aqueous fraction was centrifugally filtered through Ultrafree MC-PLHCC filter (Human
Metabolome Technology Inc.). The filtrate was dried and dissolved in Milli-Q water contain-
ing reference compounds (H3304-1004, Human Metabolome Technology Inc.). CE-TOFMS
conditions were as those reported previously [13]. Cationic metabolites were analyzed using a
fused silica capillary (50μm i.d. × 80-cm total length) with Cation Buffer Solution (Human
Metabolome Technologies) as the electrolyte. The sample was injected at a pressure of 50 mbar
for 10s. The applied voltage was set at 27kV. Electrospray ionization-mass spectrometry was
conducted in the positive ion mode, and the capillary voltage was set at 4,000V. The spectrom-
eter was scanned from 50 to 1,000 m/z. An automatic recalibration of each acquired spectrum
was performed using the masses of reference standards. For CE-MS system control and data
acquisition, we used an Agilent MassHunter software for TOFMS (Agilent Technologies). All
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target metabolites were identified by matching their m/z values and migration times with the
normalized m/z values and migration times of corresponding authentic standard compounds.
Statistical analysis
Comparisons, except for data on body weight, were made using one-way ANOVA followed by
Tukey–Kramer post-hoc tests. The hierarchical cluster analysis was performed using the statis-
tical software R. Data were expressed as means ± standard errors of the mean (SEM), and dif-
ferences were considered significant for P< 0.05, unless otherwise stated. Comparisons of
body weights were performed using repeated-measures two-way analysis of variance.
Results
HSA-Fv2E-PERK Tg mice showed AP-dependent activation of the
PERK pathway in skeletal muscles
To determine whether protein synthesis suppression inhibits the maintenance of skeletal mus-
cle and causes muscle atrophy, we characterized the previously established Tg mouse model
under the control of a human skeletal muscle actin (HSA) promoter that induces muscle-spe-
cific gene expression. The Tg mouse model expressed a chimeric protein comprising an Fv2E
regulatory domain, which undergoes ligand-induced dimerization with the artificial ligand
AP20187 (AP) and its PERK kinase domain, which is activated by dimerization (Fig 1A). The
HSA-Fv2E-PERK Tg mice were genotyped and discriminated from wild-type mice using PCR
primers for the artificial Fv2E regulatory domain (Fig 1B). eIF2α phosphorylation was very
weak in steady-state skeletal muscles of wild-type mice injected with AP. However, because
Fv2E-PERK was strongly expressed under the control of the HSA promoter in HSA-Fv2E--
PERK Tg mice, eIF2α phosphorylation was observed even at a steady state (Fig 1C). The subse-
quent intraperitoneal injections of AP induced a phosphorylation-dependent mobility shift of
Fv2E-PERK and corresponding Fv2E-PERK and eIF2α phosphorylation (Fig 1C). Wild-type
and HSA-Fv2E-PERK Tg mice were then compared in mRNA expression analyses of genes
that are induced by the PERK pathway. These RT-qPCR analyses showed that following AP
injections, the expression of Ddit3 (Chop), Ppp1r15a (Gadd34), and Trib3 mRNAs increased in
HSA-Fv2E-PERK Tg mice by 4-, 11-, and 105-fold, respectively, from that in AP-injected
wild-type mice, which had a normal activation of the PERK pathway (Fig 1D).
HSA-Fv2E-PERK Tg mice rapidly develop skeletal muscle atrophy
following injections of AP
At 6 months of age, the body weights (BWs) of the HSA-Fv2E-PERK Tg mice were slightly
lower than those of the wild-type mice. However, following daily intraperitoneal injections
of AP at 0.1 mg/kg BW, HSA-Fv2E-PERK Tg mice rapidly lost weight from the fourth day
onwards (Fig 2A). Subsequently, BWs of the HSA-Fv2E-PERK Tg mice decreased by 17.5%
from 30.5 ± 0.6 to 25.1 ± 1.0 g in 7 days (Fig 2A), corresponding with a 17% BW loss, whereas
the wild-type mice showed almost no changes in BW (Fig 2B). To specifically investigate the loss
of muscle weight following eIF2α phosphorylation, vehicle or AP (0.1 mg/kg BW) was intraperi-
toneally injected into wild-type and HSA-Fv2E-PERK Tg mice daily for 7 days, and hind limb
muscle weights were measured (Fig 2C). In the AP-injected HSA-Fv2E-PERK Tg mice, weights
of extensor digitorum longus (EDL), tibialis anterior (TA), gastrocnemius (GC), and soleus (Sol)
muscles were reduced by 29%, 24%, 18%, and 13%, respectively, compared with those of AP-
injected wild-type mice (Fig 2C). Accordingly, HE staining showed significantly higher frequen-
cies of small fibers and degenerating myofibers in the AP-injected HSA-Fv2E-PERK Tg mice
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than in the AP-injected wild-type mice or vehicle-injected HSA-Fv2E-PERK Tg mice (Fig 2D).
Muscle fiber CSA of TA muscles was reduced by 68% following AP injections in HSA-Fv2E--
PERK Tg mice, compared with those of AP-injected wild-type mice (Fig 2D).
Compensatory protein synthesis and degradation signaling but low
mitochondrial function in muscles of AP-injected HSA-Fv2E-PERK Tg
mice
Hormones such as insulin and insulin-like growth factor 1 (IGF-1) increase muscle mass by
accelerating protein synthesis and suppressing protein degradation. Moreover, Akt signaling is
Fig 1. Structure of the transgene and PERK activation in skeletal muscles of HSA-Fv2E-PERK Tg mice. (A) Schema of the transgene for skeletal
muscle-specific expression of Fv2E-PERK. (B) Representative PCR genotyping results from wild-type (WT) and HSA-Fv2E-PERK Tg mice. (C)
Representative immunoblots of phosphorylated Fv2E-PERK (P), Fv2E-PERK (non P), phosphorylated eIF2α (P), and total eIF2α (non P) in the
gastrocnemius muscles of WT and HSA-Fv2E-PERK Tg mice 8 h after intraperitoneal injections of vehicle or the artificial ligand AP21087 (AP) at 0.1
mg/kg body weight (BW). (D) RT-qPCR analyses of the expression of mRNA encoding targets of eIF2α phosphorylation in HSA-Fv2E-PERK Tg and
WT mice at 8 h after administration of vehicle or AP (0.1 mg/kg BW). Data are presented as means ± standard errors of the mean (SEM; n = 3–5), and
differences among AP-treated HSA-Fv2E-PERK Tg mice, vehicle-treated HSA-Fv2E-PERK Tg mice, and AP-treated WT mice were considered
significant at *p < 0.05 or **p < 0.01.
https://doi.org/10.1371/journal.pone.0179955.g001
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initiated by known protein synthesis hormone receptors that regulate both mTORC1 signaling
and eIF2B activity, initiating protein synthesis [14]. Therefore, we investigated changes in the
Akt and following mTORC1 signaling in AP-injected HSA-Fv2E-PERK Tg mice using immu-
noblotting experiments. Following seven daily AP injections, HSA-Fv2E-PERK Tg mice did
not show increased phospho-Akt/total Akt ratio but showed increased levels of phosphory-
lated protein/total protein ratio of the mTORC1 signaling targets, such as S6K and 4EBP1 (Fig
3A). Accordingly, eIF4E initiates translation by binding to mRNA cap structures and recruit-
ing ribosomes, whereas 4EBP1 suppresses translation by binding to eIF4E and thus inhibits
eIF4E activity. Conversely, highly phosphorylated 4EBP1 dissociates from eIF4E and activates
translation. In addition, phosphorylated S6K accelerates binding of mRNA to 40S ribosomal
subunits and promotes protein synthesis. Taken together with the present observations, these
data suggest that mTORC1 signaling for the formation of the 48S preinitiation complex are
activated in AP-injected HSA-Fv2E-PERK Tg mice.
GADD45a transcription is induced by FoxO and ATF4 [15, 16] and is reportedly induced
by various stresses that cause muscle atrophy [16, 17]. Because GADD45a is considered to be a
mediator of muscle atrophy [16], we investigated GADD45a mRNA expression in AP-injected
HSA-Fv2E-PERK Tg mice. These experiments showed 10-fold greater GADD45a expression
in HSA-Fv2E-PERK Tg mice after seven daily intraperitoneal AP injections (one per day)
compared with that in AP-injected wild-type mice (Fig 3B). Previous studies have shown that
the Akt pathway suppresses protein degradation by inactivating FoxO, which induces Fbxo32
(MAFbx) [18, 19] and Trim63 (MuRF1) [20]. These proteins are E3 ubiquitin-ligases involved
in protein degradation in skeletal muscles. Thus, we analyzed changes in the levels of Fbxo32
and Trim63 mRNA in AP-injected HSA-Fv2E-PERK Tg mice. Following 7 days of intraperito-
neal injections of AP (once per day) into HSA-Fv2E-PERK Tg mice, Fbxo32 mRNA levels
were significantly decreased to approximately 25% of those in wild-type mice (Fig 3B). These
results indicate Fbxo32 suppression in AP-injected HSA-Fv2E-PERK Tg mice, suggesting neg-
ative regulation of protein degradation.
PPARGC1A (PGC1α) regulates mitochondria biogenesis and is important for skeletal mus-
cle functions. Accordingly, PGC1α-knockout mice show the accumulation of abnormal mito-
chondria and reduced muscle mass and strength [21, 22]. Thus, we investigated PPARGC1A
mRNA expression in AP-injected HSA-Fv2E-PERK Tg mice using RT-qPCR. In these experi-
ments, PPARGC1A expression decreased in AP-injected HSA-Fv2E-PERK Tg mice to approx-
imately 25% of that in AP-injected wild-type mice after 7 days (Fig 3B), suggesting negative
regulation of mitochondrial function.
These results indicate pronounced muscle atrophy and suggest that compensatory ac-
tivation of the mTORC1 signaling leads to increased protein synthesis and suppression of
protein degradation in the muscles of AP-injected HSA-Fv2E-PERK Tg mice. In contrast,
expression of the mitochondrial regulator PPARGC1A was low in the muscles of these mice,
suggesting that eIF2α phosphorylation and signaling might be coupled with mitochondrial
biogenesis.
Fig 2. Acute skeletal muscle atrophy in AP-injected HSA-Fv2E-PERK Tg mice. (A) Body weight (BW) curves of AP-injected wild-type (WT)
male, vehicle-injected HSA-Fv2E-PERK Tg mice, and AP-injected HSA-Fv2E-PERK Tg mice; vehicle or AP (0.1 mg/kg BW) were injected
intraperitoneally once a day for 7 days (n = 5). (B) BW changes are expressed as percentages of initial BWs (Fig 2A). (C) Muscle weights of the
extensor digitorum longus (EDL), tibialis anterior (TA), gastrocnemius (GC), and soleus (Sol) muscles of AP-injected WT, vehicle-injected Tg and
AP-injected Tg mice; vehicle or AP (0.1 mg/kg BW) were intraperitoneally injected once a day for 7 days (n = 5). (D) Representative hematoxylin
and eosin (H&E) staining of TA muscles of WT and HSA-Fv2E-PERK Tg mice. Vehicle or AP (0.1 mg/kg BW) was intraperitoneally injected once a
day for 7 days. Right graph shows relative muscle cross-sectional area (CSA) of each genotype. Differences among AP-treated HSA-Fv2E-PERK
Tg mice, vehicle-treated HSA-Fv2E-PERK Tg mice, and AP-treated WT mice treated were considered significant at *p < 0.05 or **p < 0.01.
https://doi.org/10.1371/journal.pone.0179955.g002
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Fig 3. Modulation of intercellular signaling pathways that regulate skeletal muscle function in AP-injected HSA-Fv2E-PERK Tg mice. (A)
Representative immunoblots of phosphorylated Akt, total Akt, phosphorylated S6K, total S6K, phosphorylated 4EBP-1, total 4EBP-1, and GAPDH
at 8 h after vehicle or AP injections in gastrocnemius muscles of wild-type (WT) and HSA-Fv2E-PERK Tg mice; vehicle or AP (0.1-mg/kg BW) were
intraperitoneally injected once a day for 7 days. Right graphs show the band intensity from images (n = 4–5). (B) RT-qPCR analyses of mRNAs
encoding regulators of skeletal muscle function at 8 h after vehicle or AP injection in the gastrocnemius muscles of WT and HSA-Fv2E-PERK Tg
mice; vehicle or AP (0.1 mg/kg BW) were intraperitoneally injected once a day for 7 days (n = 5). Differences among AP-treated HSA-Fv2E-PERK
Tg mice, vehicle-treated HSA-Fv2E-PERK Tg mice, and AP-treated WT mice were considered significant at *p < 0.05 or **p < 0.01.
https://doi.org/10.1371/journal.pone.0179955.g003
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Impaired intracellular amino-acid homeostasis in muscles of AP-injected
HSA-Fv2E-PERK Tg mice
Protein synthesis suppression in skeletal muscles may lead to increased intracellular amino
acid levels, reflecting decreased utilization in protein synthesis. Moreover, increases in the free
amino acid levels in muscle cells stimulate the synthesis of muscle proteins and protein anabo-
lism [23], in which essential amino acids play central roles [24]. In particular, the branched
chain amino acid leucine reportedly activates the mTOR signaling pathway and stimulates
4EBP1 and S6K expression and protein anabolism [25, 26]. However, eIF2α phosphorylation
induces the translation of ATF4 and transcription of genes involved in amino acid metabolism,
such as amino acid transporters in mouse fibroblast and liver cells [27, 28]. In a recent study,
we found that genes, which are involved in serine metabolism, were induced by eIF2α phos-
phorylation in skeletal muscles [11]. These studies suggest that intracellular free amino acid
levels are closely linked to the performance of skeletal muscles. Thus, in further experiments,
we compared the intracellular amino acid profiles of 35 intracellular amino acids and related
amino compounds in skeletal muscles from AP-injected HSA-Fv2E-PERK Tg mice and wild-
type mice using liquid chromatography tandem mass spectrometry analyses. Among 20 amino
acids, cysteine was excluded because it is easily oxidized to cystine during analysis. Subse-
quently, we divided amino acid metabolites into three groups: essential amino acid group,
non-essential amino acid group, and amino compound group. Hierarchical cluster analyses
were then employed to uncover a multitude of amino acid relationships among each group.
According to the amino acid cluster formations, amino compound group was markedly dif-
ferent between AP-injected HSA-Fv2E-PERK Tg mice and wild-type mice (Fig 4A). In AP-
injected HSA-Fv2E-PERK Tg mice, increases in the levels of the branched chain amino acid
leucine and isoleucine indicate the activation of mTORC1 signaling (Fig 4B). AP-injected
HSA-Fv2E-PERK Tg mice had more ornithine, lysine, and lysine metabolite, α-aminoadipic
acid, but less ornithine metabolites, hydroxyproline and citrulline, than AP-injected wild-type
mice. On the other hand, these HSA-Fv2E-PERK Tg mice had lower levels of histidine, its
metabolites, carnosine, and anserine (Fig 4B). Furthermore, the muscle-abundant amino acids
alanine, glutamate, and taurine were present at decreased concentrations in the HSA-Fv2E--
PERK Tg mice compared with those in the wild-type mice, which was in agreement with their
reduced muscle mass. These data indicate that HSA-Fv2E-PERK Tg mice accumulate intracel-
lular free amino acids, with characteristic profiles of specific amino acid levels.
Discussion
Muscle mass loss directly contributes to intolerance to exercise and impaired daily activities,
which makes it a strong determinant of quality of life and mortality [29–31]. At present, no
therapeutic interventions are established to successfully treat muscle wasting. Therefore, the
development of model of muscle wasting is expected for exploring and validating the new
therapeutic candidates. Here, we characterized the change in the skeletal muscles of HSA-
Fv2E-PERK Tg mice treated with AP for successive 7 days. Strong and continuous eIF2α phos-
phorylation induced by AP treatment led to rapid body weight loss due to drastically reduced
muscle mass in the AP-injected HSA-Fv2E-PERK Tg mice. A metabolomic analysis of intra-
cellular free amino acid in skeletal muscles identified the characteristic profile associated with
reduced 43S preinitiation complex.
Accumulating evidence suggest that multiple concurrent processes in protein synthesis are
disturbed during muscle wasting conditions (Fig 5). In normal condition, hormones, such as
insulin and IGF-1, control skeletal muscle growth thorough Akt phosphorylation. Akt activa-
tion leads to both mTORC1 activation and glycogen synthase kinase 3β (GSK-3β) inactivation,
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leading to eIF2B GEF activity inhibition [32]. In muscle wasting condition due to disuse atro-
phy, reduced Akt1 and Akt2 expression as well as Akt phosphorylation occur [33]. Reduced
signaling through mTORC1 including decreased 4EBP1 and S6K1 phosphorylation was
observed in sarcopenia [34], sepsis-induced muscle atrophy [35], and cancer cachexia [36].
GSK-3 phosphorylation and eIF2B subunit expression were reduced in sepsis-induced muscle
atrophy [35] and sarcopenia [34]. In fact, a skeletal muscle-specific IGF1 receptor knockout
mouse model was previously developed, which showed reduced muscle fiber numbers and
sizes [37]. Moreover, a skeletal muscle-specific mTORC1 knockout mouse model was shown
to manifest skeletal muscle atrophy at 6–9 weeks of age [38, 39]. These mice carrying genetic
modifications of signals related to protein synthesis can serve as muscle wasting models. To
the best of our knowledge, there is no muscle wasting mouse model caused by repressed 43S
preinitiation complex assembly, and the HSA-Fv2E-PERK Tg mouse is the first such model.
Predominant contribution of repressed 43S preinitiation complex assembly compared with
that of 48S preinitiation complex assembly in protein synthesis has been suggested in vitro
using cultured cells [40] but has not been addressed in vivo. The AP-injected HSA-Fv2E-PERK
Tg mice led to reduced muscle mass despite the counter regulatory activation of mTORC1 sig-
naling, indicating, for the first time, that the inhibition of 43S preinitiation complex assembly
is dominant to that of 48S preinitiation complex assembly in protein synthesis in vivo. In addi-
tion, HSA-Fv2E-PERK Tg mice develop more severe and rapid skeletal muscle atrophy than
any of the previous sarcopenia mouse models, offering a superior tool for further studies.
PERK is activated by endoplasmic reticulum (ER) stress. Several reports demonstrate that
ER stress and unfolded protein response (UPR) pathway get activated under various muscle
conditions such exercise [41], aging[42], cancer cachexia[43], sepsis[44] and myopathy[45].
ER stress-induced UPR suggests to play an important role in maintaining skeletal muscle mass
and function. For example, deletion of the ATF6 branch of the UPR pathway compromised
efficient muscle recovery from acute exercise in mouse [41]. Inhibition of ER stress by a chem-
ical chaperon caused skeletal muscle wasting in cancer cachexia model mice[43]. However,
prolonged activation of the UPR pathway and unresolved ER stress can lead to many patholog-
ical processes in different tissues. Indeed, our results indicate that persistent activation of
PERK signaling reduces skeletal muscle mass. Therefore, mild and transit UPR activation
would be beneficial to the muscle but strong and continuous UPR activation would be deleteri-
ous. Because the exact roles of different arms of the UPR remain enigmatic, further investiga-
tion is needed to determine.
Inhibited protein synthesis appeared to increase the intracellular free amino acid levels, but
interestingly, not all amino acid levels increased, and some amino acid levels decreased, com-
pared with the AP-injected wild-type mice. Increased levels of branched chain amino acids,
such as leucine and isoleucine, are responsible for mTORC1 signaling activation. On the other
hands, imidazole dipeptides, such as carnosine and anserine, which are known to function as
natural antioxidants required for adaptation to anaerobic exercise, were decreased. These
altered intracellular free amino acid profiles might serve as biomarkers for reduced protein
synthesis caused by repressed 43S preinitiation complex assembly. It is interesting to note the
mechanism underlying these alternations. Other authors and we have previously reported that
Fig 4. Altered intercellular amino acid metabolism in AP-injected HSA-Fv2E-PERK Tg mice. (A) Heatmap representation of amino acid
metabolites in gastrocnemius muscles of AP-injected WT and AP-injected Tg mice (n = 5). Colors indicate ratios of determined amino acids
contents in vehicle-injected WT mice; the vertical axis is labeled with a continuous scale color bar key. AP (1-μg/kg BW) was injected
intraperitoneally. (B) Amino acid concentrations in gastrocnemius muscles of AP-injected WT, vehicle-injected Tg, and AP-injected Tg mice.
Vehicle or AP (0.1-mg/kg BW) was intraperitoneally injected once a day for 7 days (n = 5). Differences among AP-treated HSA-Fv2E-PERK Tg
mice, vehicle-treated HSA-Fv2E-PERK Tg mice, and AP-treated WT mice were considered significant at *p < 0.05 or **p < 0.01.
https://doi.org/10.1371/journal.pone.0179955.g004
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Fig 5. Schematic representation of muscle wasting in AP-injected HSA-Fv2E-PERK Tg mouse. (A) In normal condition,
hormones, such as insulin and IGF-1, stimulate protein synthesis through enhancing the formation of the 43S and 48S preinitiation
complexes, which are essential for muscle maintenance. (B) In muscle wasting conditions, signals regulating the formation of the 43S
and 48S preinitiation complex were disturbed. (C) In AP-injected HSA-Fv2E-PERK Tg mouse, inhibition of the formation of 43S
preinitiation complex by eIF2 phosphorylation led to muscle atrophy due to reduced protein synthesis, along with a counter-regulatory
increase in 48S preinitiation complex.
https://doi.org/10.1371/journal.pone.0179955.g005
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eIF2α phosphorylation regulates amino acid metabolism by inducing the amino acid trans-
porter proteins through transcriptional induction via ATF4. However, the changes in intracel-
lular free amino acids could be due to a mixed profile of inhibited eIF2B activity, increased
mTORC1 signaling, and other compensation mechanisms. Therefore, the altered profile could
not be directly attributed to the change in amino acid transport mediated by eIF2α phosphory-
lation. Further detailed analysis will be required to reveal the cooperative mechanism. Hence,
HSA-Fv2E-PERK Tg mice will facilitate future investigations of disease mechanisms and the
development of novel drugs for the treatment of muscle wasting.
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